1. Home
  2. RLMD vs BKT Comparison

RLMD vs BKT Comparison

Compare RLMD & BKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

SELL

Current Price

$3.06

Market Cap

348.8M

Sector

Health Care

ML Signal

SELL

Logo BlackRock Income Trust Inc. (The)

BKT

BlackRock Income Trust Inc. (The)

SELL

Current Price

$9.65

Market Cap

337.5M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
RLMD
BKT
Founded
2004
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
348.8M
337.5M
IPO Year
2012
1994

Fundamental Metrics

Financial Performance
Metric
RLMD
BKT
Price
$3.06
$9.65
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $10.75
N/A
AVG Volume (30 Days)
★ 1.7M
100.0K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 45.28
N/A
EPS
N/A
★ N/A
Revenue
★ $13,070.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 154.83
N/A
52 Week Low
$3.07
$9.42
52 Week High
$8.00
$11.23

Technical Indicators

Market Signals
Indicator
RLMD
BKT
Relative Strength Index (RSI) 37.32 40.27
Support Level N/A $9.50
Resistance Level $3.55 $9.69
Average True Range (ATR) 0.43 0.13
MACD -0.04 -0.03
Stochastic Oscillator 4.05 15.30

Price Performance

Historical Comparison
RLMD
BKT

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

About BKT BlackRock Income Trust Inc. (The)

Blackrock Income Trust Inc is a closed-end management investment company. Its investment objective is to manage a portfolio of high-quality securities to achieve both preservation of capital and high monthly income. The fund seeks to achieve its investment objective by investing at least 65% of its assets in mortgage-backed securities.

Share on Social Networks: